Fecal incontinence treated by sacral neuromodulation: Long-term follow-up of 325 patients

被引:39
作者
Janssen, Paul T. J. [1 ]
Kuiper, Sara Z. [1 ]
Stassen, Laurents P. S. [1 ]
Bouvy, Nicole D. [1 ]
Breukink, Stephanie O. [1 ]
Melenhorst, Jarno [1 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands
关键词
QUALITY-OF-LIFE; SF-36 HEALTH SURVEY; NERVE-STIMULATION; SINGLE-CENTER; EXPERIENCE; MODULATION; LEAD; IMPLANTATION; PREVALENCE; EFFICACY;
D O I
10.1016/j.surg.2016.10.038
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Long-term results of large patient cohorts with fecal incontinence treated by sacral neuromodulation are limited. This study shows the long-term results after a mean follow-up of 7.1 years in 325 patients with fecal incontinence treated by continuous sacral neuromodulation. Methods. All patients with fecal incontinence and eligible for sacral neuromodulation between 2000 and 2015 were evaluated retrospectively. Primary outcome was a decrease in episodes of fecal incontinence, which was defined as involuntary fecal loss at least once per week and documented by a 3 week bowel habit diary. Quality of life was assessed using the Short-Form 36 and the Fecal Incontinence Quality of Life Score. Results. In the study, 374 patients were included for sacral neuromodulation screening and 325 patients (32 male, 9.7%) received permanent, continuous sacral neuromodulation. Mean age was 56.5 years (17-82 years) and mean follow-up was 7.1 years (3.0-183.4 months). In the 325 patients with permanent sacral neuromodulation, fecal incontinence episodes decreased from a mean of 16.1 +/- 14.5 to 3.0 +/- 3.7 per 3-week period after sacral neuromodulation (P < .001) according to the bowel habit diary. Sacral neuromodulation was removed due to unsatisfactory results in 81 patients. Quality of life (both Short-Form 36 and Fecal Incontinence Quality of Life Score) showed no significant difference compared with the Dutch population during follow-up. Conclusion. Long-term efficacy of sacral neuromodulation can be maintained in about half (52.7%) of all patients screened with sacral neuromodulation for fecal incontinence after a mean follow-up of 7.1 years. Importantly, the quality of life of patients with sacral neuromodulation for fecal incontinence did not differ from the general population.
引用
收藏
页码:1040 / 1048
页数:9
相关论文
共 37 条
[1]   Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations [J].
Aaronson, NK ;
Muller, M ;
Cohen, PDA ;
Essink-Bot, ML ;
Fekkes, M ;
Sanderman, R ;
Sprangers, MAG ;
Velde, AT ;
Verrips, E .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1055-1068
[2]   Long-term outcomes of sacral nerve stimulation for faecal incontinence [J].
Altomare, D. F. ;
Giuratrabocchetta, S. ;
Knowles, C. H. ;
Munoz Duyos, A. ;
Robert-Yap, J. ;
Matzel, K. E. .
BRITISH JOURNAL OF SURGERY, 2015, 102 (04) :407-415
[3]   Long-Term Outcome of Sacral Nerve Stimulation for Fecal Incontinence [J].
Altomare, Donato F. ;
Ratto, Carlo ;
Ganio, Ezio ;
Lolli, Paola ;
Masin, Alessandra ;
Villani, Roberto D. .
DISEASES OF THE COLON & RECTUM, 2009, 52 (01) :11-17
[4]   Sacral neuromodulation in an older, urge-incontinent population [J].
Amundsen, CL ;
Webster, GD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 187 (06) :1462-1465
[5]   Predicting implantation with a neuromodulator using two different test stimulation techniques: A prospective randomized study in urge incontinent women [J].
Borawski, Kristy M. ;
Foster, Raymond T. ;
Webster, George D. ;
Amundsen, Cindy L. .
NEUROUROLOGY AND URODYNAMICS, 2007, 26 (01) :14-18
[6]   Quality of Life Is Markedly Improved in Patients With Fecal Incontinence After Sacral Nerve Stimulation [J].
Devroede, Ghislain ;
Giese, Chad ;
Wexner, Steven D. ;
Mellgren, Anders ;
Coller, John A. ;
Madoff, Robert D. ;
Hull, Tracy ;
Stromberg, Katherine ;
Iyer, Sudha .
FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2012, 18 (02) :103-112
[7]   UNITED-STATES HOUSEHOLDER SURVEY OF FUNCTIONAL GASTROINTESTINAL DISORDERS - PREVALENCE, SOCIODEMOGRAPHY, AND HEALTH IMPACT [J].
DROSSMAN, DA ;
LI, ZM ;
ANDRUZZI, E ;
TEMPLE, RD ;
TALLEY, NJ ;
THOMPSON, WG ;
WHITEHEAD, WE ;
JANSSENS, J ;
FUNCHJENSEN, P ;
CORAZZIARI, E ;
RICHTER, JE ;
KOCH, GG .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (09) :1569-1580
[8]   Sacral nerve stimulation for faecal incontinence: optimizing outcome and managing complications [J].
Dudding, T. C. ;
Hollingshead, J. R. ;
Nicholls, R. J. ;
Vaizey, C. J. .
COLORECTAL DISEASE, 2011, 13 (08) :E196-E202
[9]   Improving the efficacy of sacral nerve stimulation for faecal incontinence by alteration of stimulation parameters [J].
Dudding, T. C. ;
Vaizey, C. J. ;
Gibbs, A. ;
Kamm, M. A. .
BRITISH JOURNAL OF SURGERY, 2009, 96 (07) :778-784
[10]   Randomized double-blind crossover study of alternative stimulator settings in sacral nerve stimulation for faecal incontinence [J].
Duelund-Jakobsen, J. ;
Dudding, T. ;
Bradshaw, E. ;
Buntzen, S. ;
Lundby, L. ;
Laurberg, S. ;
Vaizey, C. .
BRITISH JOURNAL OF SURGERY, 2012, 99 (10) :1445-1452